SCHEMBL3823307

SCHEMBL3823307

CC(O)CCCCC1CCCCCCCCCCC1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ CA1 P00915 3/20 0.40
▸ CA2 P00918 3/20 0.40
▸ CA4 P22748 3/20 0.40
▸ CA6 P23280 2/20 0.40
▸ PTGS1 P23219 8/20 0.39
▸ PTGS2 P35354 8/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3823075 0.95 NPC1 (0.43) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL3817862 0.89 NPC1 (0.46) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL11058566 0.81 KDM4E (0.50) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL7146270 0.80 NPC1 (0.43) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL31619444 0.78 NPC1 (0.47) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL11413672 0.78 NPC1 (0.47) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL3823777 0.78 CA1 (0.45) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL4740933 0.78 NPC1 (0.47) NPC1RAB9AGAASMN1; SMN2ALDH1A1
SCHEMBL3818006 0.78 KDM4E (0.46) NPC1RAB9AGAASMN1; SMN2ALDH1A1
Hydrogen Peroxide SCHEMBL28783701 0.78 NPC1 (0.47) NPC1RAB9AGAASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8383834-B2 Process for preparing unsaturated lactones SYMRISE AG (DE) 2013-02-26 — — US disclosed
US-20090306411-A1 PROCESS FOR PREPARING UNSATURATED LACTONES SYMRISE GMBH & CO. KG (DE) 2009-12-10 — — US disclosed
WO-2005113533-A9 PROCESS FOR PREPARING UNSATURATED LACTONES SYMRISE GMBH & CO. KG (DE) 2009-09-24 — — WO disclosed
EP-1747211-B1 PROCESS FOR PREPARING UNSATURATED LACTONES SYMRISE GMBH & CO KG (DE) 2009-08-26 — — EP disclosed
EP-1747211-A1 PROCESS FOR PREPARING UNSATURATED LACTONES Akzo Nobel N.V. (NL) 2007-01-31 — — EP disclosed
WO-2005113533-A1 PROCESS FOR PREPARING UNSATURATED LACTONES SYMRISE GMBH & CO. KG (DE) 2005-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306411-A1 PROCESS FOR PREPARING UNSATURATED LACTONES ALOX5, ALOX12, ALOX15 NPC1 4002/4885RAB9A 4377/4885GAA 1928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback